Search results
AbbVie Is 'Firing On All Cylinders,' But Its Stock Isn't
Investor's Business Daily· 3 days agoShares tumbled despite a first-quarter beat and earnings guidance increase.
AbbVie lifts profit forecast after Skyrizi sales beat expectations
AOL· 3 days ago(Reuters) -AbbVie raised its annual profit forecast on Friday after strong sales of its immunology drug Skyrizi and cancer drug Imbruvica helped the company beat Wall Street ...
AbbVie's newer drugs are offsetting losses of the world's once best-selling medication
Quartz· 3 days agoSales of the pharma giant's newer drugs are offsetting its Humira losses.
AbbVie Inc (ABBV) Q1 2024 Earnings: Adjusted EPS Tops Estimates Despite Revenue Challenges
GuruFocus.com via Yahoo Finance· 3 days agoOn April 26, 2024, AbbVie Inc (NYSE:ABBV) released its 8-K filing, detailing the financial outcomes...
AbbVie Raises Earnings Guidance Even as Humira Sales Continue to Drop
Barrons.com· 3 days agoAbbVie raised its full-year earnings outlook despite continuing sales declines for autoimmune drug...
AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View
Zacks via Yahoo Finance· 3 days agoAbbVie Inc. ABBV reported adjusted earnings of $2.31 per share for first-quarter 2024, beating the...
AbbVie Lifts Profit Forecast After Skyrizi Sales Beat Expectations
US News & World Report· 4 days agoUS News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
AbbVie’s first-quarter results top expectations as arthritis drugs fuel growth
Market Watch· 4 days agoAbbVie Inc. on Friday reported first-quarter results that beat expectations, even as sales of...
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Zacks via Yahoo Finance· 4 days agoChicago, IL – April 25, 2024 – Today, Zacks Equity Research discusses Eli Lilly LLY, Novo Nordisk...
AbbVie Is 'Firing On All Cylinders,' But Its Stock Doesn't Show That
Investor's Business Daily· 3 days agoAbbVie is "firing on all cylinders," an analyst said Friday after the pharma giant beat Wall...